LT2211898T - Nauji trombolizės pacientų pogrupiai - Google Patents

Nauji trombolizės pacientų pogrupiai

Info

Publication number
LT2211898T
LT2211898T LTEP08838897.0T LT08838897T LT2211898T LT 2211898 T LT2211898 T LT 2211898T LT 08838897 T LT08838897 T LT 08838897T LT 2211898 T LT2211898 T LT 2211898T
Authority
LT
Lithuania
Prior art keywords
thrombolysis
patient subgroups
novel patient
novel
subgroups
Prior art date
Application number
LTEP08838897.0T
Other languages
English (en)
Inventor
Mariola Söhngen
Alice Ebel
Yasir Alaa Shafeek Al-Rawi
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40567844&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT2211898(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP07020401A external-priority patent/EP2050462A1/en
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of LT2211898T publication Critical patent/LT2211898T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Electrotherapy Devices (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
LTEP08838897.0T 2007-10-18 2008-10-20 Nauji trombolizės pacientų pogrupiai LT2211898T (lt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP07020401A EP2050462A1 (en) 2007-10-18 2007-10-18 Improved treatment of stroke patients
EP07022867 2007-11-26
EP08017954 2008-10-15
PCT/EP2008/008871 WO2009049914A2 (en) 2007-10-18 2008-10-20 Novel patient subgroups for thrombolysis

Publications (1)

Publication Number Publication Date
LT2211898T true LT2211898T (lt) 2017-01-25

Family

ID=40567844

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP08838897.0T LT2211898T (lt) 2007-10-18 2008-10-20 Nauji trombolizės pacientų pogrupiai

Country Status (29)

Country Link
US (2) US20100272704A1 (lt)
EP (1) EP2211898B1 (lt)
JP (2) JP5509085B2 (lt)
KR (1) KR20100089077A (lt)
CN (1) CN101903039B (lt)
AR (1) AR068914A1 (lt)
AU (1) AU2008314048B2 (lt)
BR (1) BRPI0817785A2 (lt)
CA (1) CA2702378A1 (lt)
CL (1) CL2009000752A1 (lt)
CY (1) CY1118417T1 (lt)
DK (1) DK2211898T3 (lt)
EA (1) EA020776B1 (lt)
ES (1) ES2611155T3 (lt)
HK (1) HK1151233A1 (lt)
HR (1) HRP20170001T1 (lt)
HU (1) HUE032867T2 (lt)
IL (1) IL205175A0 (lt)
LT (1) LT2211898T (lt)
MX (1) MX2010004157A (lt)
MY (1) MY159200A (lt)
NZ (1) NZ584640A (lt)
PL (1) PL2211898T3 (lt)
PT (1) PT2211898T (lt)
RS (1) RS55590B1 (lt)
SI (1) SI2211898T1 (lt)
TW (1) TWI482628B (lt)
WO (1) WO2009049914A2 (lt)
ZA (1) ZA201002548B (lt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10153601A1 (de) 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766075A (en) * 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
US5244806A (en) * 1985-08-26 1993-09-14 Eli Lilly And Company DNA encoding novel tissue plasminogen activator derivatives having kringles 1 and 2 deleted, vectors and host cells
IL87276A (en) * 1987-08-03 1995-07-31 Fujisawa Pharmaceutical Co Analog of a tissue plasminogen activator containing the Pringle 2 and protease regions only, DNA encoding it, processes for its preparation, and pharmaceutical preparations containing it
US5094953A (en) * 1988-03-21 1992-03-10 Genentech, Inc. Human tissue plasminogen activator variants
IE69054B1 (en) * 1988-07-20 1996-08-07 Schering Ag Vampire bat salivary plasminogen activators
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
DE3903581A1 (de) * 1989-02-07 1990-08-16 Boehringer Mannheim Gmbh Gewebs-plasminogenaktivator-derivat
US5676947A (en) * 1989-02-07 1997-10-14 Boehringer Manneheim Gmbh Method for treating thromboembolic conditions using thrombolytically active proteins
US6008019A (en) * 1989-02-13 1999-12-28 Schering Aktiengesellschaft Plasminogen activator from saliva of the vampire bat
US5891664A (en) * 1989-04-07 1999-04-06 Cancerforskningsfondet Af 1989 Vectors and methods for recombinant production of uPA-binding fragments of the human urokinase-type plasminogen receptor (uPAR)
US5326700A (en) * 1990-11-06 1994-07-05 Eli Lilly And Company DNA sequences encoding t-PA derivatives with cleavable sites
ATE132373T1 (de) * 1991-04-16 1996-01-15 Boehringer Mannheim Gmbh Pharmazeutische verpackungseinheit enthaltend plasminogenaktivatoren zur mehrfachbolusgabe
US5595736A (en) * 1991-04-22 1997-01-21 Eli Lilly And Company Compounds and methods for treatment of thromboembolic disorders
DE59307091D1 (de) * 1992-12-04 1997-09-11 Schering Ag Thrombininhibitor aus speichel von protostomiern
US5510330A (en) * 1994-03-25 1996-04-23 Boehringer Mannheim Gmbh Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof.
GB9412131D0 (en) * 1994-06-17 1994-08-10 British Bio Technology Thrombolytic composition
US5827832A (en) * 1995-03-06 1998-10-27 Interneuron Pharmaceuticals, Inc. Method of protecting brain tissue from cerebral infarction subsequent to ischemia
US5786187A (en) * 1995-09-21 1998-07-28 The Research Foundation Of State University Of New York Method for reducing neuronal degeneration associated with seizure
US5945432A (en) * 1995-12-22 1999-08-31 The University Of Vermont And State Agricultural College Thrombolytic agents and thienopyridine derivatives in acute stroke
US20020081294A1 (en) * 1996-01-23 2002-06-27 Genentech, Inc. Co-administration of a thrombolytic and an anti-CD18 antibody in stroke
US5731186A (en) * 1996-02-05 1998-03-24 Schering Aktiengesellschaft Method for the production of rDSPA α1
US6354999B1 (en) * 2000-01-14 2002-03-12 Florence Medical Ltd. System and method for detecting, localizing, and characterizing occlusions and aneurysms in a vessel
GB0025473D0 (en) * 2000-10-17 2000-11-29 Pfizer Ltd Pharmaceutical combinations
DE10153601A1 (de) * 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall
US20080057050A1 (en) * 2003-05-02 2008-03-06 Paion Deutschland Gmbh Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke
US20060135425A1 (en) * 2003-05-02 2006-06-22 Paion Deutschland Gmbh Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke
AU2004237407A1 (en) * 2003-05-05 2004-11-18 Paion Deutschland Gmbh Glutamate receptor antagonists as neuroprotectives
WO2005018564A2 (en) * 2003-08-22 2005-03-03 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a low-molecular-weight heparin for the treatment of central nervous system damage
BRPI0615266A2 (pt) * 2005-08-25 2011-05-17 Biogen Idec Inc polipeptìdeos nogo receptor e fragmentos de polipeptìdeo e usos destes

Also Published As

Publication number Publication date
US20140314736A1 (en) 2014-10-23
RS55590B1 (sr) 2017-06-30
AU2008314048B2 (en) 2013-07-25
PT2211898T (pt) 2017-01-31
AU2008314048A1 (en) 2009-04-23
CY1118417T1 (el) 2017-06-28
TW200927164A (en) 2009-07-01
EP2211898A2 (en) 2010-08-04
CN101903039B (zh) 2014-04-02
EA020776B1 (ru) 2015-01-30
CL2009000752A1 (es) 2009-12-04
MY159200A (en) 2016-12-30
HK1151233A1 (en) 2012-01-27
HRP20170001T1 (hr) 2017-02-24
PL2211898T3 (pl) 2017-03-31
KR20100089077A (ko) 2010-08-11
ES2611155T3 (es) 2017-05-05
IL205175A0 (en) 2010-11-30
JP5509085B2 (ja) 2014-06-04
ZA201002548B (en) 2011-06-29
CN101903039A (zh) 2010-12-01
BRPI0817785A2 (pt) 2015-03-24
TWI482628B (zh) 2015-05-01
EP2211898B1 (en) 2016-12-07
WO2009049914A2 (en) 2009-04-23
HUE032867T2 (en) 2017-11-28
JP2014065739A (ja) 2014-04-17
DK2211898T3 (en) 2017-01-30
MX2010004157A (es) 2010-04-30
NZ584640A (en) 2012-10-26
WO2009049914A3 (en) 2009-08-06
JP2011500617A (ja) 2011-01-06
US20100272704A1 (en) 2010-10-28
AR068914A1 (es) 2009-12-16
EA201070485A1 (ru) 2010-10-29
CA2702378A1 (en) 2009-04-23
SI2211898T1 (sl) 2017-02-28

Similar Documents

Publication Publication Date Title
ZA201000013B (en) Medical implant
EP2211620A4 (en) THERAPEUTIC COMPOUNDS
ZA201001417B (en) Medical implant
GB0620359D0 (en) Medical devices
AU312971S (en) Patient interface
GB0813087D0 (en) Therapeutic compounds
GB0716532D0 (en) Therapeutic compounds
EP2164324A4 (en) THERAPEUTIC COMPOUNDS
AU313136S (en) Patient interface
GB0719518D0 (en) Therapy
GB0617134D0 (en) Medical devices
EP2323606A4 (en) PATIENT TRANSFER
EP2236148A4 (en) MEDIinic agent for HELICOBACTER treatment
EP2185568A4 (en) THERAPEUTIC COMPOUNDS
EP2191850A4 (en) TISSUE-CONNECTABLE MATERIAL FOR MEDICAL USE
GB0702862D0 (en) Therapeutic compounds
GB0704334D0 (en) Patient bed
HK1151233A1 (en) Novel patient subgroups for thrombolysis
GB2447534B (en) Arch former
GB0717450D0 (en) Medicament
GB0708188D0 (en) Therapeutic compounds
GB0716072D0 (en) Therapy
GB0700635D0 (en) Therapy
AU312685S (en) Case for medical devices
GB0711154D0 (en) Medical implant